Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × marizomib × Other solid neoplasm × Clear all

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Interventions

tazemetostat 1 omburtamab I-131 1 molibresib 1 marizomib 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04644107 2020-11-25

Expanded Access for Marizomib

Celgene

No longer available

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡